
@ShahidNShah
The group targeted the CMS Patient Safety and Adverse Events Composite, a measure included in the 2023 Hospital Inpatient Prospective Payment System proposed rule, which Leapfrog said would effectively suppress data reported by hospitals on 10 potentially fatal care complications, from lung collapses to blood clots and pressure ulcers. Leapfrog's position is that because some hospitals are more dangerous than others, the information CMS is seeking to curtail is critical for patients seeking the best performing hospital, which can make a big difference when it comes to outcomes. With dramatic increases in the frequency and duration of ventilator use, rates of ventilator-associated infections increased by 45% in the fourth quarter of 2020, compared to 2019.
Continue reading at healthcarefinancenews.com
In this article, we summarise three concepts that are already/ will soon become familiar for everyone interested in the future of clinical trials. An artificial patient is a set of data representing …
Posted May 31, 2022 Patient Data Hybrid Clinical Trial
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm